12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Ambrx Biopharma (NYSE:AMAM) shares increased by 9.3% to $0.57 during Monday’s after-market session. This security traded at…
Ambrx Biopharma Stops Working On Breast Cancer Candidate, Cites Competition As The Reason
Ambrx Biopharma Inc (NYSE:AMAM) will prioritize ARX517 as the company’s new lead asset. The company believes ARX517 has the potential to…
Ambrx Biopharma Inc. Announces Strategic Reprioritization And Provides Corporate Update
- Company now focused on earlier stage engineered antibody drugs for cancer therapies, including new lead asset ARX517 –
- Revised focus and projected cost-reductions expected to extend cash runway into 2025
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday’s Mid-Day Session
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 62 companies set new 52-week lows.
Ambrx Announces Abrupt Leadership Change, Discuses Pipeline Review
Kate Hermans has taken over the reins of Ambrx Biopharma Inc (NASDAQ:AMAM) as interim CEO following the abrupt departure of Feng Tian,…